Literature DB >> 6466353

The inhibition of Ca uptake in cardiac membrane vesicles by verapamil.

A Erdreich, H Rahamimoff.   

Abstract

Cardiac membrane vesicles take up Ca2+ in response to Na+ gradient (high inside) and negative inside membrane potential. Both components of the Ca2+ uptake, the Na+ gradient dependent uptake and the membrane potential dependent uptake are inhibited by verapamil; the action is dose-dependent and the concentrations of verapamil required to inhibit the Ca2+ uptake to 50% of its maximal value are 50 and 60 microM respectively. In the concentration ranges tested (50-750 microM Ca2+), the inhibitory effect of verapamil could not be antagonized by increasing the Ca2+ concentration of the medium. Introducing verapamil into the vesicles by rapid freezing and slow thawing of the vesicles had the same inhibitory effect as adding the same concentration of verapamil on the outside of the vesicles. Adding verapamil to both sides of the vesicle membrane led to higher inhibition of Ca2+ uptake. It is proposed that addition of verapamil can cause a change in cardiac membranes which is manifested by a decrease in the driving membrane potential and Ca2+ transport.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6466353     DOI: 10.1016/0006-2952(84)90672-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Electrogenic sodium-calcium exchange in cultured embryonic chick heart cells.

Authors:  R Jacob; M Lieberman; S Liu
Journal:  J Physiol       Date:  1987-06       Impact factor: 5.182

Review 2.  The role of Na+/Ca2+ exchanger subtypes in neuronal ischemic injury.

Authors:  Botros Shenoda
Journal:  Transl Stroke Res       Date:  2015-04-11       Impact factor: 6.829

3.  The cardioplegic solution HTK: effects on membrane potential, intracellular K+ and Na+ activities in sheep cardiac Purkinje fibres.

Authors:  E Krohn; B Stinner; M Fleckenstein; M M Gebhard; H J Bretschneider
Journal:  Pflugers Arch       Date:  1989-12       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.